摘要
随着医药行业的高速发展,保险在医药行业风险管理领域的作用日益明显。本文结合医药行业相关保险政策要求,对截至2022年底北京中卫保险经纪有限公司参与的部分医药行业保险业务数据进行分析,介绍保险在医药行业风险管理中的作用,简述行业风险周期长、复杂性高的特点以及药物Ⅰ期临床试验和肿瘤临床试验理赔高发的趋势,为医药企业及保险公司评估行业风险提供参考。
With the rapid development of the pharmaceutical industry,the role of insurance in risk management is becoming increasingly obvious.Based on the requirements of relevant insurance policies in the pharmaceutical industry,this paper analyzes some insurance business data of the pharmaceutical industry in which Bejing Zhongwei Insurance Brokers Co.,Ltd.participated as of the end of 2022.It introduces the role of insurance in risk management in the pharmaceutical industry,briefly describe the characteristics of the industry's long risk cycle and high complexity,and the trend of high compensation incidence of drug phase I clinical trials and tumor clinical trials.To provide reference for pharmaceutical enterprises and insurance companies to evaluate industry risks.
作者
孙健
曹丽君
SUN Jian;CAO Li-jun(Bejing Zhongwei Insurance Brokers Co.,Ltd.,BEIJING 100101,China)
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2023年第10期655-658,共4页
Chinese Journal of New Drugs and Clinical Remedies
关键词
临床试验
保险
受试者
风险管理
上市许可持有人
clinical trials
insurance
subjects
risk management
marketing authorization holder